Studies on “Final Common Pathways” Associated with Cardiomyopathies and Arrythmias

Dr. Jeffrey A. Towbin is the Executive Co-Director of the Heart Institute and Professor & Chief of Pediatric Cardiology at Le Bonheur Children’s Hospital and St. Jude Children’s Research Hospital, as well as Vice Chair of Pediatrics for Strategic Advancement at the University of Tennessee Health Science Center in Memphis. He received his B.S (1974) and M.S in Cell Biology (1977) from the University of Cincinnati, his M.D. degree from the University of Cincinnati College of Medicine (1982), and he did his Pediatric Residency at Cincinnati Children’s Hospital (1982-1985) before moving to Houston to do his Pediatric Cardiology Fellowship and translational research training in Cardiovascular Genetics at Texas Children’s Hospital and Baylor College of Medicine (1985-1989). He joined the Pediatric Cardiology faculty of Baylor College of Medicine and Texas Children’s Hospital in July 1989 and was ultimately promoted to the rank of Tenured Professor in 1998, becoming Chief of Pediatric Cardiology from 2003-2009 and elevating the ranking of the program to #3 in US News and World Report. Dr. Towbin relocated back to Cincinnati Children’s Hospital Medical Center in 2009 as Executive Co-Director of the Heart Institute and Tenured Professor & Chief of Pediatric Cardiology and built the Heart Institute with recruitment of over 40 faculty and elevating the program to a #5 ranking. He arrived in Memphis in February 2015 to take on his current roles. Within 3 years, the program went from being unranked to being ranked #10.

Dr. Towbin’s expertise is in the clinical and translational arenas of Pediatric Cardiomyopathy, Heart Failure, Heart Transplantation, and causes of arrhythmic sudden death. His current focus is on the genetic and acquired forms and mechanisms responsible for cardiomyopathies with and without heart failure or arrhythmias and cardio-skeletal myopathies. He has also trained and mentored many of the Division Chiefs of Pediatric Cardiology and Chairs of Pediatrics, which is his most cherished accomplishment.

Learning Objectives:

  1. Define the key genetic targets that cause the clinical features of cardiomyopathies and arrhythmias
  2. Define the key protein targets that cause the clinical features of cardiomyopathies and arrhythmias
  3. Determine whether genetics has importance in the care of children and adults with cardiomyopathies and arrhythmias


  • Jeffrey A. Towbin, MD, MS

This seminar was delivered as a Pediatric Grand Rounds Lecture at Children’s Hospital of Philadelphia, on May 15, 2024.

Content Disclaimer

The Terms of Use and Privacy Policy set forth on the website of The Children’s Hospital of Philadelphia apply to any and all uses of and access to this site and the content found here.

The work presented in the presentations, videos, and other content on this site (“Presentations”) includes publicly available medical evidence, a consensus of medical practitioners, and/or opinions of individual practitioners that may differ from consensus opinions. These Presentations are intended only to provide general information and need to be adapted for each specific patient based on the practitioner’s professional judgment, consideration of any unique circumstances, the needs of each patient and their family, the availability of various resources at the health care institution where the patient is located, and other factors. The Presentations are not intended to constitute medical advice or treatment, nor should they be relied upon as such. The Presentations are not intended to create a doctor-patient relationship between/among The Children’s Hospital of Philadelphia, its physicians and the individual patients in question. The information contained in these Presentations are general in nature, and do not and are not intended to refer to specific patients.

CHOP, The Children’s Hospital of Philadelphia Foundation and its or their affiliates, the authors, presenters, practitioners, editors, and others associated with the creation of the Presentations (“CHOP”) are not responsible for errors or omissions in the Presentations; for any outcomes a patient might experience where a clinician reviewed one or more such Presentations in connection with providing care for that patient; and/or for any and all third party content on the site or in the Presentations. CHOP makes no warranty, expressed or implied, with respect to the currency, completeness, applicability or accuracy of the Presentations. Application of the information in or to a particular situation remains the professional responsibility of the practitioner who is directly treating the patient.

To the extent that the Presentations include information regarding drug dosing, in view of ongoing research, changes in government regulations and the constant flow of information relating to drug therapy and drug reactions, the viewer should not rely on the Presentation content, but rather is urged to check the package insert for each drug for indications, dosage, warnings and precautions.

Some drugs and medical devices presented in the Presentations have United States Food and Drug Administration (FDA) clearance for limited use in restricted research settings. It is the responsibility of the practitioner to ascertain the FDA status of each drug or device planned for use in their clinical practice.

You shall indemnify, defend and hold harmless CHOP, The Children’s Hospital of Philadelphia Foundation, and its/their current and former employees, officers, and agents, trustees, and their respective successors, heirs and assigns (“Indemnitees”) against any claims, liability, damage, loss or expenses (including attorneys’ fees and expenses of litigation) in connection with any claims, suits, actions, demands or judgments arising directly or indirectly out of your reference to or use of the Presentations.

The Presentations are protected by copyright laws and in some cases patent laws, and all rights are reserved under such laws. No part of the Presentations may be reproduced in any form by any means, or utilized in any other way, absent prior written permission from the copyright owner.


By starting this module, you agree to our Content Disclaimer and Terms of Service.


Course Includes

  • 1 Lesson
  • Course Certificate
Don't have a CHOP OPEN account?
Click “Login to Enroll” below to register for free.